C5 Insight, based in Charlotte, North Carolina, was named in an article posted on CustomerThink’s site as one of the world’s Top 10 SharePoint development companies. According to the article, C5 Insight’s “team of developers is fiercely passionate on helping organizations accelerate the adoption of a digital workplace as well as marketing technologies like Microsoft SharePoint, Salesforce.com, and Dynamics CRM. The company firmly believes that success in business relies on people, on plans and processes. Technology must work for people and not the other way around.”
CustomerThink is a global community of business professionals dedicated to customer-centric business. CustomerThink was founded by Bob Thompson, Editor-in-Chief, in 2000 as CRMGuru.com. It’s mission is to help business leaders develop and implement customer-centric business strategies by conducting research on key issues and trends; publishing high-quality articles and blogs; and by facilitating interactions with a global panel of experts.
C5 Insight is led by Founder and Managing Partner Geoff Ables. Ables is also a best selling author and speaker. He is the author of “The LUCK Principle: Business Results at the Intersection of People & Profit.” In the book he teaches how to harness the power of people, process, and technology to transform a business into a workplace that balances a people-first culture with bottom-line results. The book is available in both paperback and Kindle versions on Amazon at https://www.Amazon.com/dp/B01N0QW5H4.
C5 Insight was founded in 2002 and is a leader in delivering customer engagement and employee collaboration projects. The company has consulted with hundreds of companies around the world in a broad range of industries. The firm has twice been named to the Inc. 5000 list of fastest growing companies. For more information about C5 Insight, visit https://www.C5Insight.com.
Latest posts by Sarah Thompson (see all)
- AbbVie Presents New Late-Breaking Phase 2b Data on Upadacitinib in Atopic Dermatitis at the 2018 American Academy of Dermatology Annual Meeting - February 17, 2018
- AbbVie Presents New Positive Late-Breaking Data from Two Phase 3 Psoriasis Trials of Risankizumab at the 2018 American Academy of Dermatology Annual Meeting - February 17, 2018
- AnaptysBio Presents Updated Data from ANB020 Phase 2a Atopic Dermatitis Trial at AAD Annual Meeting - February 17, 2018